The MDR-TB Planning Toolkit is designed to help assist countries develop or strengthen a multidrug-resistant tuberculosis (MDR-TB) component within their national TB strategy or plan. Eight tools contain worksheets to assist the user through key planning steps. The toolkit is intended for countries, technical partners, international organizations, and donors.
These stories highlight the personal experiences of several people who were diagnosed and treated for TB disease, as well as the work of TB control professionals. You can share individual stories on social media using the social media graphics included on several of the survivor story pages.
This fact sheet presents TB morbidity rates for Hispanic/Latino persons in the United States. These statistics emphasize the need to eliminate TB and to focus on preventing and controlling TB in this minority group.
The TB Contact Investigation Interviewing Skills Course is an interactive, skills-building training. It is designed to improve the knowledge and proficiency of both new and experienced TB program staff.
This guideline provides guidance on the principles and evidence-informed recommendations on the nutritional care and support for patients with tuberculosis.
This guide provides a summary of safety and efficacy data for drugs currently in use to treat TB. The guide also suggests advocacy points for activists, clinicians, and others working in TB.
The purpose of this training toolkit is to build the capacity of health care workers to address and manage TB in children. The toolkit consists of ten modules. Topics include epidemiology of childhood TB, diagnosis, treatment, prevention, TB/HIV co-infection, multidrug-resistant TB, and community-based child TB management.
This series of patient education fact sheets provides information on drugs used in the treatment of TB (e.g., Clofazimine, Ethambutol, Ethionamide, Isoniazid, Levofloxacin, Moxifloxacin, PASER [p-aminosalicylic acid granules], Pyrazinamide, Pyridoxine, Rifabutin, Rifampin, Streptomycin). The fact sheets include information on medication side effects, actions to take if side effects occur, and instructions in the event a dose of medication is missed.
The goal of these materials is to teach patients about TB infection and to motivate them to start and complete treatment if diagnosed. The materials are designed to encourage provider-patient interactions for active learning through the process of testing and treatment decisions. There are four materials in this series and it is suggested to use the materials as a continuum, as they build upon each other.
This 60-minute webinar was created for public and private clinicians and allied health personnel who work with pediatric tuberculosis.
